Ph.D., SVP, Head of Research, Calibrate
Biography
Dr. Jennifer Lovejoy is a senior executive and biobehavioral scientist with deep experience in personalized medicine. During her academic career, Dr. Lovejoy held the Manship Endowed Professorship in Diabetes at LSU's Pennington Biomedical Research Center. She is a Past-President of the Obesity Society and has published over 80 peer-reviewed papers on her research. More recently, Dr. Lovejoy was Chief Translational Science Officer at Arivale, a precision medicine startup uniting systems biology and behavioral science to help consumers optimize wellness. Currently, she is the SVP, Head of Research at Calibrate, a company that combines FDA-approved weight loss medications with personalized lifestyle interventions to help individuals improve metabolic health.
Session Abstract – PMWC 2022 Silicon Valley
Track 5 - June 28 11.15 A.M.-12.00 P.M.
Panel
Session Abstract – PMWC 2022 Silicon Valley
Track 5 - June 28 1.00 P.M.-1.45 P.M.
Panel
Session Abstract – PMWC 2022 Silicon Valley
Track 7 - June 29 10.00 A.M.-3.00 P.M.
The PMWC 2022 Wellness & Aging Showcase will provide a 15-minute time slot for selected companies in Wellness and Aging to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from selected companies that build innovative solutions and harness the power of digital health, genomics, and data science with the goal to proactively prevent disease, maintain optimal health, and slow down aging.
